Will Pfizer Slash Its >7% Yielding Dividend? I Wouldn't Rule It Out

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Pfizer (NYSE: PFE ) is arguably the biggest victim of the radical new healthcare policies being brought about by the Trump administration, and in my view, this means that its dividend - currently yielding >7% perTh ...